Related Experiment Videos
[Metabolic emergencies in oncology: hypercalcemia. I. Pathogenesis]
C Ficorella1, S Tomao, P Cagnazzo
1Dipartimento di Medicina Sperimentale, Oncologia Medica, Università degli Studi de L'Aquila.
La Clinica Terapeutica
|February 15, 1990
Summary
Cancer-related metabolic abnormalities, like hypercalcemia, pose a significant threat. Prompt diagnosis and treatment of hypercalcemia (high blood calcium) are crucial for patient survival and enabling chemotherapy.
Area of Science:
- Oncology
- Endocrinology
- Internal Medicine
Background:
- Metabolic abnormalities in cancer patients can be life-threatening.
- Hypercalcemia is a common complication, affecting up to 30% of cancer patients.
- Timely intervention for hypercalcemia can be life-saving and facilitate cancer treatment.
Purpose of the Study:
- To elucidate the pathogenetic mechanisms of cancer-associated hypercalcemia.
- To detail the diagnostic approaches for hypercalcemia in neoplastic disease.
- To outline the subsequent treatment strategies for this metabolic disorder.
Main Methods:
- Review of pathogenetic mechanisms of hypercalcemia.
- Analysis of diagnostic criteria for hypercalcemia.
- Evaluation of treatment protocols for hypercalcemia.
Main Results:
- Detailed explanation of the causes of hypercalcemia in cancer.
- Comprehensive diagnostic guidelines provided.
- Effective treatment options discussed.
Conclusions:
- Hypercalcemia is a critical metabolic complication of cancer.
- Understanding pathogenesis is key to diagnosis and treatment.
- Effective management of hypercalcemia improves patient outcomes and allows for continued cancer therapy.